Skip to content

Clinical study on the development and efficacy evaluation of Enhanced Recovery After Surgery (ERAS) in Microvascular Decompression (MVD)

Clinical study on the development and efficacy evaluation of Enhanced Recovery After Surgery (ERAS) in Microvascular Decompression (MVD)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17012002
Enrollment
Unknown
Registered
2017-07-15
Start date
2017-07-14
Completion date
Unknown
Last updated
2017-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

microvascular decompression, trigeminal neuralgia, hemifacial spasm, glossopharyngsal neuralgia

Interventions

ERAS Group:Perioperative ERAS protocol for MVD

Sponsors

Department of neurosurgery, Tangdu Hospital, Fourth Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Patients with idiopathic TN, HFS and GN who need MVD surgery; (2) Aged between 18-80 years; (3) Patients of selective surgery; (4) Patients who are able to communicate well with the medical staff; (5) Patients who understand and sign the Informed Consent,with good compliance in the study.

Exclusion criteria

Exclusion criteria: (1) Patients with secondary TN, HFS and GN who need MVD surgery; (2) Patients with recurrent TN, HFS and GN who need anther MVD surgery; (3) serious complications of disease (blood system, respiratory system, digestive system, etc.) patients; (4) patients with severe heart disease (such as coronary heart disease, myocardial infarction, etc.); (5) Patients with ULN and / or renal function (Cr)> 1.5 times ULN with liver function (ALT, AST)> 2 times; (6) patients with mental illness or severe mental illness; (7) Women who have a childcare plan within 6 months of pregnancy or breastfeeding; (8) Other patients who were considered unsuitable for inclusion in the study.

Design outcomes

Primary

MeasureTime frame
operational time;VAS score;Wound complication;Length of stay after surgery;electroneurophysiological monitoring;intraoperative fluid infusion;KPS score;Postoperative complication rate;Preventive antithrombotic therapy;skin preparation method;Preoperative fasting water treatment;intraoperational blood loss;Incision suture method;Drainage tube placement;Prevention of epilepsy treatment;Nausea, vomiting treatment;Hospitalization cost;Postoperative pain management;mucosa protection;NRS2002;ASA score;PONV prevention;Foley's catheter placement time;

Countries

China

Contacts

Public ContactXuelian Wang

Tangdu Hospital, The Fourth Military Medical University

tdwxlian@126.com+86 13609182869

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026